{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:56:13Z","timestamp":1787003773838,"version":"build-2736575974"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-13558-3","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T14:17:37Z","timestamp":1753539457000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Longitudinal dynamics of clinical and neurophysiological changes in parkinson\u2019s disease over four and a half years"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7901-0444","authenticated-orcid":false,"given":"Estefan\u00eda","family":"Santana-Rom\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1667-2253","authenticated-orcid":false,"given":"Emmanuel","family":"Ortega-Robles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9982-7571","authenticated-orcid":false,"given":"Oscar","family":"Arias-Carri\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"key":"13558_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.neubiorev.2016.07.010","volume":"68","author":"AA Moustafa","year":"2016","unstructured":"Moustafa, A. A. et al. Motor symptoms in parkinson\u2019s disease: A unified framework. Neurosci. Biobehav Rev. 68, 727\u2013740. https:\/\/doi.org\/10.1016\/j.neubiorev.2016.07.010 (2016).","journal-title":"Neurosci. Biobehav Rev."},{"key":"13558_CR2","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/s1474-4422(06)70373-8","volume":"5","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri, K. R., Healy, D. G. & Schapira, A. H. Non-motor symptoms of parkinson\u2019s disease: diagnosis and management. Lancet Neurol. 5, 235\u2013245. https:\/\/doi.org\/10.1016\/s1474-4422(06)70373-8 (2006).","journal-title":"Lancet Neurol."},{"key":"13558_CR3","doi-asserted-by":"publisher","first-page":"100180","DOI":"10.1016\/j.prdoa.2022.100180","volume":"8","author":"B Lacy","year":"2023","unstructured":"Lacy, B., Piotrowski, H. J., Dewey, R. B. Jr. & Husain, M. M. Severity of depressive and motor symptoms impacts quality of life in parkinson\u2019s disease patients at an academic movement clinic: A cross-sectional study. Clin. Park Relat. Disord. 8, 100180. https:\/\/doi.org\/10.1016\/j.prdoa.2022.100180 (2023).","journal-title":"Clin. Park Relat. Disord"},{"key":"13558_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/mdc3.12553","volume":"5","author":"SK Holden","year":"2018","unstructured":"Holden, S. K., Finseth, T., Sillau, S. H. & Berman, B. D. Progression of MDS-UPDRS scores over five years in de Novo Parkinson disease from the parkinson\u2019s progression markers initiative cohort. Mov. Disord Clin. Pract. 5, 47\u201353. https:\/\/doi.org\/10.1002\/mdc3.12553 (2018).","journal-title":"Mov. Disord Clin. Pract."},{"key":"13558_CR5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3233\/jpd-212860","volume":"12","author":"M Bartl","year":"2022","unstructured":"Bartl, M. et al. Longitudinal change and progression indicators using the movement disorder Society-Unified parkinson\u2019s disease rating scale in two independent cohorts with early parkinson\u2019s disease. J. Parkinsons Dis. 12, 437\u2013452. https:\/\/doi.org\/10.3233\/jpd-212860 (2022).","journal-title":"J. Parkinsons Dis."},{"key":"13558_CR6","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ana.26373","volume":"92","author":"K Furukawa","year":"2022","unstructured":"Furukawa, K. et al. Motor progression and nigrostriatal neurodegeneration in Parkinson disease. Ann. Neurol. 92, 110\u2013121. https:\/\/doi.org\/10.1002\/ana.26373 (2022).","journal-title":"Ann. Neurol."},{"key":"13558_CR7","doi-asserted-by":"publisher","first-page":"1186484","DOI":"10.3389\/fnsyn.2023.1186484","volume":"15","author":"DJ Surmeier","year":"2023","unstructured":"Surmeier, D. J., Zhai, S., Cui, Q. & Simmons, D. V. Rethinking the network determinants of motor disability in parkinson\u2019s disease. Front. Synaptic Neurosci. 15, 1186484. https:\/\/doi.org\/10.3389\/fnsyn.2023.1186484 (2023).","journal-title":"Front. Synaptic Neurosci."},{"key":"13558_CR8","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1016\/j.neubiorev.2013.09.008","volume":"37","author":"D Lindenbach","year":"2013","unstructured":"Lindenbach, D. & Bishop, C. Critical involvement of the motor cortex in the pathophysiology and treatment of parkinson\u2019s disease. Neurosci. Biobehav Rev. 37, 2737\u20132750. https:\/\/doi.org\/10.1016\/j.neubiorev.2013.09.008 (2013).","journal-title":"Neurosci. Biobehav Rev."},{"key":"13558_CR9","doi-asserted-by":"publisher","first-page":"105159","DOI":"10.1016\/j.nbd.2020.105159","volume":"147","author":"CF Underwood","year":"2021","unstructured":"Underwood, C. F. & Parr-Brownlie, L. C. Primary motor cortex in parkinson\u2019s disease: functional changes and opportunities for neurostimulation. Neurobiol. Dis. 147, 105159. https:\/\/doi.org\/10.1016\/j.nbd.2020.105159 (2021).","journal-title":"Neurobiol. Dis."},{"key":"13558_CR10","doi-asserted-by":"publisher","unstructured":"de la Fuente-Fern\u00e1ndez, R. Frontostriatal cognitive staging in Parkinson\u2019s disease. Parkinsons Dis. 561046, (2012). https:\/\/doi.org\/10.1155\/2012\/561046 (2012).","DOI":"10.1155\/2012\/561046"},{"key":"13558_CR11","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/s10548-023-00965-w","volume":"36","author":"LI Boon","year":"2023","unstructured":"Boon, L. I. et al. Cortical and subcortical changes in MEG activity reflect parkinson\u2019s progression over a period of 7 years. Brain Topogr. 36, 566\u2013580. https:\/\/doi.org\/10.1007\/s10548-023-00965-w (2023).","journal-title":"Brain Topogr"},{"key":"13558_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s44194-022-00015-w","volume":"1","author":"Z Ye","year":"2022","unstructured":"Ye, Z. Mapping neuromodulatory systems in parkinson\u2019s disease: lessons learned beyond dopamine. Curr. Med. 1, 15. https:\/\/doi.org\/10.1007\/s44194-022-00015-w (2022).","journal-title":"Curr. Med."},{"key":"13558_CR13","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/S0140-6736(85)92413-4","volume":"325","author":"AT Barker","year":"1985","unstructured":"Barker, A. T., Jalinous, R. & Freeston, I. L. Non-invasive magnetic stimulation of human motor cortex. Lancet 325, 1106\u20131107. https:\/\/doi.org\/10.1016\/S0140-6736(85)92413-4 (1985).","journal-title":"Lancet"},{"key":"13558_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0208-5216(11)70013-4","volume":"31","author":"JC Rothwell","year":"2011","unstructured":"Rothwell, J. C. Transcranial magnetic stimulation: Twenty years of stimulating the human motor cortex in health and disease. Biocybern Biomed. Eng. 31, 81\u201391. https:\/\/doi.org\/10.1016\/S0208-5216(11)70013-4 (2011).","journal-title":"Biocybern Biomed. Eng."},{"key":"13558_CR15","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.clinph.2015.02.001","volume":"126","author":"PM Rossini","year":"2015","unstructured":"Rossini, P. M. et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord, roots and peripheral nerves: basic principles and procedures for routine clinical and research application. An updated report from an IFCN committee. Clin. Neurophysiol. 126, 1071\u20131107. https:\/\/doi.org\/10.1016\/j.clinph.2015.02.001 (2015).","journal-title":"Clin. Neurophysiol."},{"key":"13558_CR16","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/s0165-0173(01)00158-8","volume":"38","author":"R Cantello","year":"2002","unstructured":"Cantello, R., Tarletti, R. & Civardi, C. Transcranial magnetic stimulation and parkinson\u2019s disease. Brain Res. Brain Res. Rev. 38, 309\u2013327. https:\/\/doi.org\/10.1016\/s0165-0173(01)00158-8 (2002).","journal-title":"Brain Res. Brain Res. Rev."},{"key":"13558_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40035-015-0045-x","volume":"4","author":"Z Ni","year":"2015","unstructured":"Ni, Z. & Chen, R. Transcranial magnetic stimulation to understand pathophysiology and as potential treatment for neurodegenerative diseases. Transl Neurodegener. 4, 22. https:\/\/doi.org\/10.1186\/s40035-015-0045-x (2015).","journal-title":"Transl Neurodegener"},{"key":"13558_CR18","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.brs.2013.05.004","volume":"6","author":"F Spagnolo","year":"2013","unstructured":"Spagnolo, F. et al. Interhemispheric balance in parkinson\u2019s disease: a transcranial magnetic stimulation study. Brain Stimul. 6, 892\u2013897. https:\/\/doi.org\/10.1016\/j.brs.2013.05.004 (2013).","journal-title":"Brain Stimul"},{"issue":"Pt 2","key":"13558_CR19","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/brain\/117.2.317","volume":"117","author":"A Priori","year":"1994","unstructured":"Priori, A., Berardelli, A., Inghilleri, M., Accornero, N. & Manfredi, M. Motor cortical Inhibition and the dopaminergic system. Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with parkinson\u2019s disease and drug-induced parkinsonism. Brain 117 (Pt 2), 317\u2013323. https:\/\/doi.org\/10.1093\/brain\/117.2.317 (1994).","journal-title":"Brain"},{"key":"13558_CR20","first-page":"825","volume":"48","author":"H Shimamoto","year":"1996","unstructured":"Shimamoto, H. et al. [Motor evoked potentials of transcranial magnetic stimulation for parkinson\u2019s disease]. No Shinkei. 48, 825\u2013829 (1996).","journal-title":"No Shinkei"},{"key":"13558_CR21","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1212\/WNL.0b013e3182919029","volume":"80","author":"Z Ni","year":"2013","unstructured":"Ni, Z., Bahl, N., Gunraj, C. A., Mazzella, F. & Chen, R. Increased motor cortical facilitation and decreased Inhibition in Parkinson disease. Neurology 80, 1746\u20131753. https:\/\/doi.org\/10.1212\/WNL.0b013e3182919029 (2013).","journal-title":"Neurology"},{"key":"13558_CR22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.clinph.2023.03.010","volume":"150","author":"S Vucic","year":"2023","unstructured":"Vucic, S. et al. Clinical diagnostic utility of transcranial magnetic stimulation in neurological disorders. Updated report of an IFCN committee. Clin. Neurophysiol. 150, 131\u2013175. https:\/\/doi.org\/10.1016\/j.clinph.2023.03.010 (2023). https:\/\/doi.org\/https:\/\/doi.org\/","journal-title":"Clin. Neurophysiol."},{"key":"13558_CR23","doi-asserted-by":"publisher","unstructured":"Birreci, D. et al. The role of Non-Invasive brain modulation in identifying disease biomarkers for diagnostic and therapeutic purposes in parkinsonism. Brain Sci. 14 https:\/\/doi.org\/10.3390\/brainsci14070695 (2024).","DOI":"10.3390\/brainsci14070695"},{"key":"13558_CR24","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/S1388-2457(00)00316-3","volume":"111","author":"AP Strafella","year":"2000","unstructured":"Strafella, A. P. et al. Effects of chronic Levodopa and Pergolide treatment on cortical excitability in patients with parkinson\u2019s disease: a transcranial magnetic stimulation study. Clin. Neurophysiol. 111, 1198\u20131202. https:\/\/doi.org\/10.1016\/S1388-2457(00)00316-3 (2000).","journal-title":"Clin. Neurophysiol."},{"key":"13558_CR25","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1002\/mds.26167","volume":"30","author":"M Kojovic","year":"2015","unstructured":"Kojovic, M. et al. Transcranial magnetic stimulation follow-up study in early parkinson\u2019s disease: A decline in compensation with disease progression? Mov. Disord. 30, 1098\u20131106. https:\/\/doi.org\/10.1002\/mds.26167 (2015).","journal-title":"Mov. Disord"},{"key":"13558_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.brs.2021.11.016","volume":"15","author":"A Guerra","year":"2022","unstructured":"Guerra, A. et al. Long-term changes in short-interval intracortical facilitation modulate motor cortex plasticity and L-dopa-induced dyskinesia in parkinson\u2019s disease. Brain Stimul. 15, 99\u2013108. https:\/\/doi.org\/10.1016\/j.brs.2021.11.016 (2022).","journal-title":"Brain Stimul"},{"issue":"Suppl 4","key":"13558_CR27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/s1353-8020(09)70831-4","volume":"15","author":"W Poewe","year":"2009","unstructured":"Poewe, W. & Mahlknecht, P. The clinical progression of parkinson\u2019s disease. Parkinsonism Relat. Disord. 15 (Suppl 4), 28\u201332. https:\/\/doi.org\/10.1016\/s1353-8020(09)70831-4 (2009).","journal-title":"Parkinsonism Relat. Disord"},{"key":"13558_CR28","doi-asserted-by":"publisher","unstructured":"Arya, R. et al. Parkinson\u2019s Disease: Biomarkers for Diagnosis and Disease Progression. Int. J. Mol. Sci. 25 https:\/\/doi.org\/10.3390\/ijms252212379 (2024).","DOI":"10.3390\/ijms252212379"},{"key":"13558_CR29","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1212\/01.wnl.0000183359.50822.f2","volume":"65","author":"G Alves","year":"2005","unstructured":"Alves, G., Wentzel-Larsen, T., Aarsland, D. & Larsen, J. P. Progression of motor impairment and disability in Parkinson disease: a population-based study. Neurology 65, 1436\u20131441. https:\/\/doi.org\/10.1212\/01.wnl.0000183359.50822.f2 (2005).","journal-title":"Neurology"},{"key":"13558_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.parkreldis.2014.10.026","volume":"21","author":"P Mart\u00ednez-Mart\u00edn","year":"2015","unstructured":"Mart\u00ednez-Mart\u00edn, P. et al. Parkinson\u2019s disease severity levels and MDS-Unified parkinson\u2019s disease rating scale. Parkinsonism Relat. Disord. 21, 50\u201354. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.10.026 (2015).","journal-title":"Parkinsonism Relat. Disord"},{"key":"13558_CR31","doi-asserted-by":"publisher","first-page":"106065","DOI":"10.1016\/j.parkreldis.2024.106065","volume":"123","author":"S Aslam","year":"2024","unstructured":"Aslam, S., Manfredsson, F., Stokes, A. & Shill, H. Advanced parkinson\u2019s disease: A review. Parkinsonism Relat. Disord. 123, 106065. https:\/\/doi.org\/10.1016\/j.parkreldis.2024.106065 (2024).","journal-title":"Parkinsonism Relat. Disord"},{"key":"13558_CR32","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1007\/s00415-019-09348-3","volume":"266","author":"A Regnault","year":"2019","unstructured":"Regnault, A. et al. Does the MDS-UPDRS provide the precision to assess progression in early parkinson\u2019s disease? Learnings from the parkinson\u2019s progression marker initiative cohort. J. Neurol. 266, 1927\u20131936. https:\/\/doi.org\/10.1007\/s00415-019-09348-3 (2019).","journal-title":"J. Neurol."},{"key":"13558_CR33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/mds.21198","volume":"22","author":"CG Goetz","year":"2007","unstructured":"Goetz, C. G. et al. Movement disorder Society-sponsored revision of the unified parkinson\u2019s disease rating scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov. Disord. 22, 41\u201347. https:\/\/doi.org\/10.1002\/mds.21198 (2007).","journal-title":"Mov. Disord"},{"key":"13558_CR34","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1212\/01.Wnl.0000163993.82388.C8","volume":"64","author":"RJ Uitti","year":"2005","unstructured":"Uitti, R. J., Baba, Y., Whaley, N. R., Wszolek, Z. K. & Putzke, J. D. Parkinson disease: handedness predicts asymmetry. Neurology 64, 1925\u20131930. https:\/\/doi.org\/10.1212\/01.Wnl.0000163993.82388.C8 (2005).","journal-title":"Neurology"},{"key":"13558_CR35","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/mds.26107","volume":"30","author":"J Marinus","year":"2015","unstructured":"Marinus, J. & van Hilten, J. J. The significance of motor (a)symmetry in parkinson\u2019s disease. Mov. Disord. 30, 379\u2013385. https:\/\/doi.org\/10.1002\/mds.26107 (2015).","journal-title":"Mov. Disord"},{"key":"13558_CR36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jns.2018.08.001","volume":"393","author":"C Miller-Patterson","year":"2018","unstructured":"Miller-Patterson, C. et al. Motor asymmetry over time in parkinson\u2019s disease. J. Neurol. Sci. 393, 14\u201317. https:\/\/doi.org\/10.1016\/j.jns.2018.08.001 (2018).","journal-title":"J. Neurol. Sci."},{"key":"13558_CR37","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1002\/mds.28682","volume":"36","author":"E Fiorenzato","year":"2021","unstructured":"Fiorenzato, E., Antonini, A., Bisiacchi, P., Weis, L. & Biundo, R. Asymmetric dopamine transporter loss affects cognitive and motor progression in parkinson\u2019s disease. Mov. Disord. 36, 2303\u20132313. https:\/\/doi.org\/10.1002\/mds.28682 (2021).","journal-title":"Mov. Disord"},{"key":"13558_CR38","doi-asserted-by":"crossref","unstructured":"Falla, M. et al. Lockdown effects on parkinson\u2019s disease during COVID-19 pandemic: a pilot study. Acta Neurol. Belg. 121, 1191\u20131198. https:\/\/doi.org\/10.1007\/s13760-021-01732-z (2021).","DOI":"10.1007\/s13760-021-01732-z"},{"key":"13558_CR39","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41531-022-00376-x","volume":"8","author":"A Shalash","year":"2022","unstructured":"Shalash, A. et al. A 6-month longitudinal study on worsening of parkinson\u2019s disease during the COVID-19 pandemic. NPJ Parkinsons Dis. 8, 111. https:\/\/doi.org\/10.1038\/s41531-022-00376-x (2022).","journal-title":"NPJ Parkinsons Dis."},{"key":"13558_CR40","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.3233\/JPD-212779","volume":"11","author":"C Ineichen","year":"2021","unstructured":"Ineichen, C., Baumann-Vogel, H., Sitzler, M., Waldvogel, D. & Baumann, C. R. Worsened parkinson\u2019s disease progression: impact of the COVID-19 pandemic. J. Parkinson Dis. 11, 1579\u20131583. https:\/\/doi.org\/10.3233\/JPD-212779 (2021).","journal-title":"J. Parkinson Dis."},{"key":"13558_CR41","doi-asserted-by":"publisher","first-page":"845","DOI":"10.3233\/jpd-230061","volume":"13","author":"C Ineichen","year":"2023","unstructured":"Ineichen, C., Vogel-Baumann, H., Sitzler, M., Deuschl, G. & Baumann, C. R. Worsening of parkinson\u2019s disease after termination of COVID-19 quarantine cannot be reversed despite resumption of physiotherapy. J. Parkinsons Dis. 13, 845\u2013848. https:\/\/doi.org\/10.3233\/jpd-230061 (2023).","journal-title":"J. Parkinsons Dis."},{"key":"13558_CR42","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1007\/s00415-012-6557-8","volume":"259","author":"A Antonini","year":"2012","unstructured":"Antonini, A. et al. The progression of non-motor symptoms in parkinson\u2019s disease and their contribution to motor disability and quality of life. J. Neurol. 259, 2621\u20132631. https:\/\/doi.org\/10.1007\/s00415-012-6557-8 (2012).","journal-title":"J. Neurol."},{"key":"13558_CR43","doi-asserted-by":"publisher","first-page":"14781","DOI":"10.1038\/s41598-021-94255-9","volume":"11","author":"YC Chen","year":"2021","unstructured":"Chen, Y. C. et al. The severity progression of non-motor symptoms in parkinson\u2019s disease: a 6-year longitudinal study in Taiwanese patients. Sci. Rep. 11, 14781. https:\/\/doi.org\/10.1038\/s41598-021-94255-9 (2021).","journal-title":"Sci. Rep."},{"key":"13558_CR44","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41531-021-00207-5","volume":"7","author":"R Ou","year":"2021","unstructured":"Ou, R. et al. Longitudinal evolution of non-motor symptoms in early parkinson\u2019s disease: a 3-year prospective cohort study. NPJ Parkinsons Dis. 7, 58. https:\/\/doi.org\/10.1038\/s41531-021-00207-5 (2021).","journal-title":"NPJ Parkinsons Dis."},{"key":"13558_CR45","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/mdc3.13262","volume":"8","author":"P Bugalho","year":"2021","unstructured":"Bugalho, P. et al. Progression in parkinson\u2019s disease: variation in motor and non-motor symptoms severity and predictors of decline in cognition, motor function, disability, and health\u2010related quality of life as assessed by two different methods. Mov. Disord Clin. Pract. 8, 885\u2013895. https:\/\/doi.org\/10.1002\/mdc3.13262 (2021).","journal-title":"Mov. Disord Clin. Pract."},{"key":"13558_CR46","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/mds.27790","volume":"34","author":"LJW Evers","year":"2019","unstructured":"Evers, L. J. W., Krijthe, J. H., Meinders, M. J., Bloem, B. R. & Heskes, T. M. Measuring parkinson\u2019s disease over time: the real-world within-subject reliability of the MDS-UPDRS. Mov. Disord. 34, 1480\u20131487. https:\/\/doi.org\/10.1002\/mds.27790 (2019).","journal-title":"Mov. Disord"},{"key":"13558_CR47","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.neucli.2021.08.002","volume":"51","author":"EM Khedr","year":"2021","unstructured":"Khedr, E. M., Lefaucheur, J. P., Hasan, A. M. & Osama, K. Are there differences in cortical excitability between akinetic-rigid and tremor-dominant subtypes of parkinson\u2019s disease? Neurophysiol. Clin. 51, 443\u2013453. https:\/\/doi.org\/10.1016\/j.neucli.2021.08.002 (2021).","journal-title":"Neurophysiol. Clin."},{"key":"13558_CR48","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.clinph.2004.11.017","volume":"116","author":"JP Lefaucheur","year":"2005","unstructured":"Lefaucheur, J. P. Motor cortex dysfunction revealed by cortical excitability studies in parkinson\u2019s disease: influence of antiparkinsonian treatment and cortical stimulation. Clin. Neurophysiol. 116, 244\u2013253. https:\/\/doi.org\/10.1016\/j.clinph.2004.11.017 (2005).","journal-title":"Clin. Neurophysiol."},{"key":"13558_CR49","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1002\/mds.27870","volume":"34","author":"K Kolmancic","year":"2019","unstructured":"Kolmancic, K. et al. Sex differences in parkinson\u2019s disease: A transcranial magnetic stimulation study. Mov. Disord. 34, 1873\u20131881. https:\/\/doi.org\/10.1002\/mds.27870 (2019).","journal-title":"Mov. Disord"},{"key":"13558_CR50","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.cnp.2022.06.002","volume":"7","author":"R Chen","year":"2022","unstructured":"Chen, R. et al. Clinical neurophysiology of parkinson\u2019s disease and parkinsonism. Clin. Neurophysiol. Pract. 7, 201\u2013227. https:\/\/doi.org\/10.1016\/j.cnp.2022.06.002 (2022).","journal-title":"Clin. Neurophysiol. Pract."},{"key":"13558_CR51","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3233\/jpd-191683","volume":"9","author":"S Cerri","year":"2019","unstructured":"Cerri, S., Mus, L. & Blandini, F. Parkinson\u2019s disease in women and men: what\u2019s the difference?? J. Parkinsons Dis. 9, 501\u2013515. https:\/\/doi.org\/10.3233\/jpd-191683 (2019).","journal-title":"J. Parkinsons Dis."},{"key":"13558_CR52","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1136\/jnnp-2015-312283","volume":"87","author":"F Moisan","year":"2016","unstructured":"Moisan, F. et al. Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis. J. Neurol. Neurosurg. Psychiatry. 87, 952\u2013957. https:\/\/doi.org\/10.1136\/jnnp-2015-312283 (2016).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"13558_CR53","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/mds.28312","volume":"36","author":"H Iwaki","year":"2021","unstructured":"Iwaki, H. et al. Differences in the presentation and progression of parkinson\u2019s disease by sex. Mov. Disord. 36, 106\u2013117. https:\/\/doi.org\/10.1002\/mds.28312 (2021).","journal-title":"Mov. Disord"},{"key":"13558_CR54","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.parkreldis.2019.10.019","volume":"69","author":"DS Abraham","year":"2019","unstructured":"Abraham, D. S. et al. Sex differences in parkinson\u2019s disease presentation and progression. Parkinsonism Relat. Disord. 69, 48\u201354. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.10.019 (2019).","journal-title":"Parkinsonism Relat. Disord"},{"key":"13558_CR55","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.jogn.2016.05.002","volume":"45","author":"N Dahodwala","year":"2016","unstructured":"Dahodwala, N., Pei, Q. & Schmidt, P. Sex differences in the clinical progression of parkinson\u2019s disease. J. Obstet. Gynecol. Neonatal Nurs. 45, 749\u2013756. https:\/\/doi.org\/10.1016\/j.jogn.2016.05.002 (2016).","journal-title":"J. Obstet. Gynecol. Neonatal Nurs."},{"key":"13558_CR56","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1017\/cjn.2022.83","volume":"50","author":"S Choudhury","year":"2023","unstructured":"Choudhury, S. et al. Short-Latency afferent Inhibition correlates with stage of disease in parkinson\u2019s patients. Can. J. Neurol. Sci. 50, 579\u2013583. https:\/\/doi.org\/10.1017\/cjn.2022.83 (2023).","journal-title":"Can. J. Neurol. Sci."},{"key":"13558_CR57","doi-asserted-by":"publisher","first-page":"fcae020","DOI":"10.1093\/braincomms\/fcae020","volume":"6","author":"G Paparella","year":"2024","unstructured":"Paparella, G. et al. Interhemispheric imbalance and bradykinesia features in parkinson\u2019s disease. Brain Commun. 6, fcae020. https:\/\/doi.org\/10.1093\/braincomms\/fcae020 (2024).","journal-title":"Brain Commun."},{"key":"13558_CR58","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1212\/wnl.0000000000200787","volume":"99","author":"JM Janssen Daalen","year":"2022","unstructured":"Janssen Daalen, J. M., Schootemeijer, S., Richard, E., Darweesh, S. K. L. & Bloem, B. R. Lifestyle interventions for the prevention of Parkinson disease: A recipe for action. Neurology 99, 42\u201351. https:\/\/doi.org\/10.1212\/wnl.0000000000200787 (2022).","journal-title":"Neurology"},{"key":"13558_CR59","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1146\/annurev.pharmtox.41.1.625","volume":"41","author":"PL Chan","year":"2001","unstructured":"Chan, P. L. & Holford, N. H. Drug treatment effects on disease progression. Annu. Rev. Pharmacol. Toxicol. 41, 625\u2013659. https:\/\/doi.org\/10.1146\/annurev.pharmtox.41.1.625 (2001).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"13558_CR60","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1001\/archneur.62.3.378","volume":"62","author":"R Hilker","year":"2005","unstructured":"Hilker, R. et al. Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity. Arch. Neurol. 62, 378\u2013382. https:\/\/doi.org\/10.1001\/archneur.62.3.378 (2005).","journal-title":"Arch. Neurol."},{"key":"13558_CR61","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/psp4.13112","volume":"13","author":"R Jin","year":"2024","unstructured":"Jin, R., Yoshioka, H., Sato, H. & Hisaka, A. Data-driven disease progression model of parkinson\u2019s disease and effect of sex and genetic variants. CPT Pharmacometrics Syst. Pharmacol. 13, 649\u2013659. https:\/\/doi.org\/10.1002\/psp4.13112 (2024).","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"13558_CR62","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.parkreldis.2014.10.017","volume":"21","author":"J Zhang","year":"2015","unstructured":"Zhang, J. et al. Akinetic-rigid and tremor-dominant parkinson\u2019s disease patients show different patterns of intrinsic brain activity. Parkinsonism Relat. Disord. 21, 23\u201330. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.10.017 (2015).","journal-title":"Parkinsonism Relat. Disord"},{"key":"13558_CR63","doi-asserted-by":"publisher","first-page":"113733","DOI":"10.1016\/j.bbr.2022.113733","volume":"422","author":"N Kamble","year":"2022","unstructured":"Kamble, N. et al. Cortical excitability changes as a marker of cognitive impairment in parkinson\u2019s disease. Behav. Brain Res. 422, 113733. https:\/\/doi.org\/10.1016\/j.bbr.2022.113733 (2022).","journal-title":"Behav. Brain Res."},{"key":"13558_CR64","doi-asserted-by":"publisher","first-page":"11828","DOI":"10.1038\/ncomms11828","volume":"7","author":"JQM Ly","year":"2016","unstructured":"Ly, J. Q. M. et al. Circadian regulation of human cortical excitability. Nat. Commun. 7, 11828. https:\/\/doi.org\/10.1038\/ncomms11828 (2016).","journal-title":"Nat. Commun."},{"key":"13558_CR65","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/j.brs.2019.06.012","volume":"12","author":"A Guerra","year":"2019","unstructured":"Guerra, A. et al. Abnormal cortical facilitation and L-dopa-induced dyskinesia in parkinson\u2019s disease. Brain Stimul. 12, 1517\u20131525. https:\/\/doi.org\/10.1016\/j.brs.2019.06.012 (2019).","journal-title":"Brain Stimul"},{"key":"13558_CR66","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. MDS clinical diagnostic criteria for parkinson\u2019s disease. Mov. Disord. 30, 1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424 (2015).","journal-title":"Mov. Disord"},{"key":"13558_CR67","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.parkreldis.2013.01.007","volume":"19","author":"M Vonloh","year":"2013","unstructured":"Vonloh, M., Chen, R. & Kluger, B. Safety of transcranial magnetic stimulation in parkinson\u2019s disease: a review of the literature. Parkinsonism Relat. Disord. 19, 573\u2013585. https:\/\/doi.org\/10.1016\/j.parkreldis.2013.01.007 (2013).","journal-title":"Parkinsonism Relat. Disord"},{"key":"13558_CR68","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.clinph.2020.10.003","volume":"132","author":"S Rossi","year":"2021","unstructured":"Rossi, S. et al. Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: expert guidelines. Clin. Neurophysiol. 132, 269\u2013306. https:\/\/doi.org\/10.1016\/j.clinph.2020.10.003 (2021).","journal-title":"Clin. Neurophysiol."},{"key":"13558_CR69","doi-asserted-by":"crossref","unstructured":"Edwards, D. J. et al. in In A Practical Manual for Transcranial Magnetic Stimulation. Edwards15\u201333 (eds Dylan, J.) (Springer Nature Switzerland, 2024).","DOI":"10.1007\/978-3-031-62304-2_2"},{"key":"13558_CR70","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1136\/jnnp.2005.062950","volume":"76","author":"AJ Espay","year":"2005","unstructured":"Espay, A. J., Li, J. Y., Johnston, L., Chen, R. & Lang, A. E. Mirror movements in parkinsonism: evaluation of a new clinical sign. J. Neurol. Neurosurg. Psychiatry. 76, 1355\u20131358. https:\/\/doi.org\/10.1136\/jnnp.2005.062950 (2005).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"13558_CR71","doi-asserted-by":"publisher","first-page":"102451","DOI":"10.1016\/j.mex.2023.102451","volume":"11","author":"E Ortega-Robles","year":"2023","unstructured":"Ortega-Robles, E., Cantillo-Negrete, J. & Carino-Escobar, R. I. Arias-Carri\u00f3n, O. Methodological approach for assessing motor cortical excitability changes with single-pulse transcranial magnetic stimulation. MethodsX 11, 102451. https:\/\/doi.org\/10.1016\/j.mex.2023.102451 (2023).","journal-title":"MethodsX"},{"key":"13558_CR72","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1109\/TNSRE.2019.2925904","volume":"27","author":"P Julkunen","year":"2019","unstructured":"Julkunen, P. Mobile application for adaptive threshold hunting in transcranial magnetic stimulation. IEEE Trans. Neural Syst. Rehabil Eng. 27, 1504\u20131510. https:\/\/doi.org\/10.1109\/TNSRE.2019.2925904 (2019).","journal-title":"IEEE Trans. Neural Syst. Rehabil Eng."},{"key":"13558_CR73","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/PL00005641","volume":"114","author":"H Devanne","year":"1997","unstructured":"Devanne, H., Lavoie, B. A. & Capaday, C. Input-output properties and gain changes in the human corticospinal pathway. Exp. Brain Res. 114, 329\u2013338. https:\/\/doi.org\/10.1007\/PL00005641 (1997).","journal-title":"Exp. Brain Res."},{"key":"13558_CR74","doi-asserted-by":"publisher","first-page":"8225","DOI":"10.1038\/s41598-023-34801-9","volume":"13","author":"D Milardovich","year":"2023","unstructured":"Milardovich, D. et al. DELMEP: a deep learning algorithm for automated annotation of motor evoked potential latencies. Sci. Rep. 13, 8225. https:\/\/doi.org\/10.1038\/s41598-023-34801-9 (2023).","journal-title":"Sci. Rep."},{"key":"13558_CR75","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.brs.2013.01.016","volume":"6","author":"RG Carson","year":"2013","unstructured":"Carson, R. G. et al. Characterizing changes in the excitability of corticospinal projections to proximal muscles of the upper limb. Brain Stimul. 6, 760\u2013768. https:\/\/doi.org\/10.1016\/j.brs.2013.01.016 (2013).","journal-title":"Brain Stimul"},{"key":"13558_CR76","doi-asserted-by":"publisher","first-page":"20190720","DOI":"10.1098\/rspb.2019.0720","volume":"286","author":"SN Geniole","year":"2019","unstructured":"Geniole, S. N. et al. Testosterone reduces the threat premium in competitive resource division. Proc. Biol. Sci. 286, 20190720. https:\/\/doi.org\/10.1098\/rspb.2019.0720 (2019).","journal-title":"Proc. Biol. Sci."},{"key":"13558_CR77","doi-asserted-by":"publisher","unstructured":"G\u00f3mez, Y. et al. Similarity in Temporal movement patterns in laying hens increases with time and social association. Anim. (Basel). 12 https:\/\/doi.org\/10.3390\/ani12050555 (2022).","DOI":"10.3390\/ani12050555"},{"key":"13558_CR78","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1136\/bmj.310.6977.446","volume":"310","author":"JM Bland","year":"1995","unstructured":"Bland, J. M. & Altman, D. G. Calculating correlation coefficients with repeated observations: part 1\u2014Correlation within subjects. Bmj 310, 446. https:\/\/doi.org\/10.1136\/bmj.310.6977.446 (1995).","journal-title":"Bmj"},{"key":"13558_CR79","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1136\/bmj.310.6980.633","volume":"310","author":"JM Bland","year":"1995","unstructured":"Bland, J. M. & Altman, D. G. Calculating correlation coefficients with repeated observations: part 2\u2014Correlation between subjects. Bmj 310, 633. https:\/\/doi.org\/10.1136\/bmj.310.6980.633 (1995).","journal-title":"Bmj"},{"key":"13558_CR80","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. (4.4.1). (2024). https:\/\/www.R-project.org\/"},{"key":"13558_CR81","unstructured":"Posit team. RStudio: Integrated Development Environment for R. (2023.06.1). (2023). http:\/\/www.posit.co\/"},{"key":"13558_CR82","unstructured":"Kassambara, A. ggpubr: \u2018ggplot2\u2019 Based Publication Ready Plots. (0.6.0). (2023). https:\/\/CRAN.R-project.org\/package=ggpubr"},{"key":"13558_CR83","unstructured":"Kassambara, A. Pipe-Friendly Framework for Basic Statistical Tests. (0.7.2). (2023). https:\/\/CRAN.R-project.org\/package=rstatix"},{"key":"13558_CR84","unstructured":"Wickham, H., Vaughan, D. & Girlich, M. Tidy Messy Data. (1.3.1). (2024). https:\/\/CRAN.R-project.org\/package=tidyr"},{"key":"13558_CR85","unstructured":"Dawson, C. ggprism: A \u2018ggplot2\u2019 Extension Inspired by \u2018GraphPad Prism\u2019. (1.0.5). (2024). https:\/\/CRAN.R-project.org\/package=ggprism"},{"key":"13558_CR86","unstructured":"Wilke, C. O. & cowplot Streamlined Plot Theme and Plot Annotations for \u2018ggplot2\u2019. (1.1.1). (2020). https:\/\/CRAN.R-project.org\/package=cowplot"},{"key":"13558_CR87","unstructured":"Fox, J., Weisberg, S. & Third An {R} Companion to Applied Regression. (). (2019). https:\/\/socialsciences.mcmaster.ca\/jfox\/Books\/Companion\/"},{"key":"13558_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","volume":"67","author":"D Bates","year":"2015","unstructured":"Bates, D., M\u00e4chler, M., Bolker, B. & Walker, S. Fitting linear Mixed-Effects models using lme4. J. Stat. Softw. 67, 1\u201348. https:\/\/doi.org\/10.18637\/jss.v067.i01 (2015).","journal-title":"J. Stat. Softw."},{"key":"13558_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v075.i06","volume":"75","author":"M Koller","year":"2016","unstructured":"Koller, M. & robustlmm An R package for robust Estimation of linear Mixed-Effects models. J. Stat. Softw. 75, 1\u201324. https:\/\/doi.org\/10.18637\/jss.v075.i06 (2016).","journal-title":"J. Stat. Softw."},{"key":"13558_CR90","unstructured":"Lenth, R. V. & emmeans Estimated Marginal Means, aka Least-Squares Means. (1.10.3). (2024). https:\/\/CRAN.R-project.org\/package=emmeans"},{"key":"13558_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v082.i13","volume":"82","author":"A Kuznetsova","year":"2017","unstructured":"Kuznetsova, A., Brockhoff, P. B. & Christensen, R. H. B. LmerTest package: tests in linear mixed effects models. J. Stat. Softw. 82, 1\u201326. https:\/\/doi.org\/10.18637\/jss.v082.i13 (2017).","journal-title":"J. Stat. Softw."},{"key":"13558_CR92","unstructured":"Elzhov, T. V., Mullen, K. M., Spiess, A. N. & Bolker, B. minpack.lm: R interface to the Levenberg-Marquardt nonlinear Least-Squares algorithm found in MINPACK, plus support for bounds. (1.2.4). (2023). https:\/\/CRAN.R-project.org\/package=minpack.lm"},{"key":"13558_CR93","unstructured":"Bakdash, J. Z., Marusich, L. R. & rmcorr Repeated Measures Correlation (0.7.0). (2024). https:\/\/CRAN.R-project.org\/package=rmcorr"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13558-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13558-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13558-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T19:04:03Z","timestamp":1753902243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13558-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13558"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-13558-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6246415\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"17 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27284"}}